T2 Biosystems to Report First Quarter 2020 Financial Results on May 5, 2020
April 21 2020 - 4:22PM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens, announced today that it will
report financial results for the first quarter of 2020 after market
close on Tuesday, May 5, 2020. Company management will host a
corresponding conference call beginning at 4:30 p.m. Eastern
Time.
Investors interested in listening to the conference call may do
so by accessing a live and archived webcast of the event
at www.t2biosystems.com, on the Investors page in the Events
& Presentations section. The call will also be available by
dialing 800-263-0877 (U.S.) or 856-344-9283 (International) five to
ten minutes prior to the start time.
About T2 Biosystems:T2 Biosystems, a
leader in the rapid detection of sepsis-causing pathogens, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, the T2Bacteria® Panel, and the T2ResistanceTM
Panel and are powered by the proprietary T2 Magnetic Resonance
(T2MR®) technology. T2 Biosystems has an active pipeline of future
products, including products for the detection of additional
species and antibiotic resistance markers of sepsis pathogens, and
tests for Lyme disease.
Media Contact: Gina Kent, Vault
Communications gkent@vaultcommunications.com 610-455-2763
Investor Contact: Philip Trip Taylor, Gilmartin
Group philip@gilmartinIR.com 415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024